pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
usnoflast
Amyotrophic Lateral Sclerosis
Zydus Lifesciences Ltd
0
catalysts
Phase 2
utenpanium chloride
Obesity
Raziel Therapeutics
0
catalysts
Phase 2
utidelone
utidelone [INN]
Breast Cancer
BioStar Pharmaceuticals Inc
0
catalysts
Phase 2
uzatresgene autoleucel
Ovarian Cancer
← prev
page 51 of 53
next →
131
Pain
89
Neurology
1
US WorldMeds LLC
0
catalysts
Phase 2
vabametkib
vabametkib [INN]
Non-Small Cell Lung Cancer
Abion Inc
0
catalysts
Phase 2
vadernersen sodium
X Chromosome Disorders
$IONS
IONIS PHARMACEUTICALS INC
0
catalysts
Phase 2
vafidemstat
vafidemstat [INN]
Borderline Personality Disorder (BPD)
Oryzon Genomics SA
0
catalysts
Phase 2
valemetostat
valemetostat [INN]
Non-Small Cell Lung Cancer
Daiichi Sankyo Co Ltd
0
catalysts
Phase 2
vamotinib
vamotinib [INN]
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Fusion Pharmaceuticals Inc
0
catalysts
Phase 2
vandefitemcel
vandefitemcel [INN]
Traumatic Brain Injury
SanBio Co Ltd
0
catalysts
Phase 2
vanoglipel
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$MTVA
MetaVia Inc.
0
catalysts
Phase 2
vardenafil hydrochloride
Vardenafil Hydrochloride (vardenafil hydrochloride)
Pulmonary Arterial Hypertension
cGMP-specific 3',5'-cyclic phosphodiesterase
Respira Therapeutics Inc
0
catalysts
Phase 2
varespladib methyl
Poisoning
Group 10 secretory phospholipase A2
Phospholipase A2, membrane associated
Ophirex Inc
0
catalysts
Phase 2
vebreltinib DR
vebreltinib
Glioblastoma Multiforme (GBM)
$APLM
Apollomics Inc.
0
catalysts
Phase 2
vemzatatug vedotin
vemzatatug vedotin[INN]
Refractory Multiple Myeloma
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
venadaparib
venadaparib [INN]
Gastric Cancer
Idience Co Ltd
0
catalysts
Phase 2
vepafestinib
vepafestinib [INN]
Non-Small Cell Lung Cancer
Helsinn Healthcare SA
0
catalysts
Phase 2
verekitug
Nasal Polyps (Nasal Polyposis)
$UPB
Upstream Bio, Inc.
0
catalysts
Phase 2
vididencel
vididencel [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Mendus AB
0
catalysts
Phase 2
vilastobart
Cervical Cancer
$XLO
Xilio Therapeutics, Inc.
0
catalysts
Phase 2
vilobelimab
Gohibic (vilobelimab)
Acute Respiratory Distress Syndrome
Complement C5
InflaRx NV
0
catalysts
Phase 2
vinorelbine tartrate
Vinorelbine Tartrate (vinorelbine tartrate)
Soft Tissue Sarcoma
Tubulin
Taiwan Liposome Co Ltd
0
catalysts
Phase 2
visepegenatide
visepegenatide [INN]
Type 2 Diabetes
PegBio Co Ltd
0
catalysts
Phase 2
visugromab
Metastatic Hepatocellular Carcinoma (HCC)
Catalym GmbH
0
catalysts
Phase 2
vocacapsaicin hydrochloride
Post-Operative Pain
Concentric Analgesics Inc
0
catalysts
Phase 2
vodobatinib
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Tyrosine-protein kinase ABL1
Bcr/Abl fusion protein
Sun Pharma Advanced Research Company Ltd
0
catalysts
Phase 2
volagidemab
Type 1 Diabetes (Juvenile Diabetes)
Glucagon receptor
Remd Biotherapeutics Inc
0
catalysts
Phase 2
volixibat potassium
Pruritus
$MIRM
Mirum Pharmaceuticals, Inc.
0
catalysts
Phase 2
vonafexor
vonafexor [INN]
Alport Syndrome
Enyo Pharma SA
0
catalysts
Phase 2
vopimetostat
vopimetostat [INN]
Bladder Cancer
$TNGX
Tango Therapeutics, Inc.
0
catalysts
